dr. lyman on educating physicians about biosimilars in oncology
Published 4 years ago • 56 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:59
dr. lyman on the process for approving biosimilars
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
1:16
dr gary lyman sees knowledge of biosimilars in cancer has improved
-
2:00
dr. lyman on g-csf biosimilars and potential impact on the market
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
1:08
dr. litton discusses the potential advantage of using biosimilars in oncology
-
4:20
the biosimilar development process
-
4:09
better understanding biosimilar medications
-
7:06
latest news & insight: january 15, 2015
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
0:52
dr. offin on potential implications of introducing biosimilars into oncology
-
1:50
dr. somer on education for biosimilars
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
0:53
dr. schmid on evaluating biosimilars in oncology
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
0:54
dr. schmid on the role of biosimilars in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
5:56
the complexity of choosing biosimilars in oncology
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
0:55
dr. weise discusses the value of biosimilars in oncology